| MERDX | VSGAX | MERDX / VSGAX | |
| Total Expense Ratio | 0.91 | 0.07 | 1,300% |
| Annual Report Gross Expense Ratio | 0.91 | 0.07 | 1,300% |
| Fund Existence | 41 years | 14 years | - |
| Gain YTD | -3.605 | 11.740 | -31% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 678M | 39.7B | 2% |
| Annual Yield % from dividends | 0.00 | 0.54 | - |
| Returns for 1 year | -8.18 | 4.92 | -166% |
| Returns for 3 years | -0.03 | 50.61 | -0% |
| Returns for 5 years | -24.97 | 22.89 | -109% |
| Returns for 10 years | 2.96 | 168.29 | 2% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 40.05 | 0.24 | +0.60% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| TOLZ | 54.11 | 0.21 | +0.39% |
| ProShares DJ Brookfield Global Infras | |||
| SPEM | 47.26 | -0.05 | -0.11% |
| SPDR® Portfolio Emerging Markets ETF | |||
| HLAL | 62.71 | -0.09 | -0.14% |
| Wahed FTSE USA Shariah ETF | |||
| SOXY | 61.32 | -0.64 | -1.03% |
| YieldMax Target 12 Smcndctr Opt Inc ETF | |||